logo

For the Inventor, By the Inventor

Wheaton, MD, United States of America

Janice B Allen

This inventor holds 3 USPTO granted patents. Top assignees: Regents of the University of Minnesota, The United States of America as Represented by the Department of Health, The United States of America as Represented by the Secretary of Health. Active years: 1995-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Janice B Allen. Retrieved from https://idiyas.com/inventor/janice-b-allen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 58(Granted Patents)


Location History:

  • Angier, NC (US) (1995)
  • Wheaton, MD (US) (1997)
  • Wendell, NC (US) (1998)

Company Filing History:

goldMedal1 out of 2,372 
 
Regents of the University of Minnesota
 patents
silverMedal1 out of 1,217 
 
The United States of America as Represented by the Department of Health
 patents
bronzeMedal1 out of 28 
 
The United States of America as Represented by the Secretary of Health
 patents
4. 1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1995-1998

Loading Chart...
3 patents (USPTO):Explore Patents
1. 5840691 - Method for treating ischemia using polypeptides with fibronectin activity (1998-11-24),
2. 5591719 - Method for treating acute and chronic inflammatory disorders using (1997-01-07),
3. 5449688 - Method of treating chronic inflammatory diseases (1995-09-12),

Title: Janice B Allen: Innovator in Polypeptide Therapeutics

Introduction

Janice B Allen is a prominent inventor based in Wheaton, MD (US). She has made significant contributions to the field of medical therapeutics, particularly through her innovative work with polypeptides. With a total of 3 patents to her name, her research focuses on methods for treating ischemia and inflammatory disorders.

Latest Patents

One of her latest patents is a method for treating ischemia using polypeptides with fibronectin activity. This method involves administering an effective amount of polypeptides that correspond to specific amino acid sequences from fibronectin. Another notable patent addresses the treatment of acute and chronic inflammatory disorders using similar polypeptides. This method aims to suppress inflammation and improve tissue function in patients.

Career Highlights

Throughout her career, Janice has worked with the United States of America as represented by the Department of Health. Her work has been instrumental in advancing therapeutic techniques that leverage the properties of fibronectin-related polypeptides.

Collaborations

Janice has collaborated with notable professionals in her field, including Sharon M Wahl and Leo T Furcht. These collaborations have further enriched her research and contributed to her innovative approaches in medical treatments.

Conclusion

Janice B Allen's contributions to the field of polypeptide therapeutics highlight her role as a leading inventor. Her innovative methods for treating ischemia and inflammatory disorders continue to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…